Navigation Links
Study examines risk of heterosexual HIV transmission in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province. Since 2007, heterosexual transmission has replaced injecting drug use as the primary transmission mode of all HIV infections in China. The study is available online in advance of publication in the journal Sexually Transmitted Infections.

"We found a large burden of syphilis infection coupled with high-risk sexual and substance use behaviors among male clients of sex workers," said Cui Yang, lead author of the study and a postdoctoral fellow with Bloomberg School's Department of Epidemiology. "Without effective interventions to prevent HIV transmission to the male client population, the current epidemic may expand into the general population."

For the study, Yang and her colleagues examined the prevalence of HIV, syphilis and hepatitis C virus (HCV) in a sample of 600 male clients of female sex workers in three urban areas in Sichuan province, China. Blood test results indicated that HIV prevalence was 1.5 percent; 5.3 percent were positive for syphilis and 8.7 percent positive for HCV. The overall prevalence of consistent condom use with female sex workers was 30 percent. The study also found a significant correlation between syphilis infection among male clients and not having local household registration, snorting heroin and washing genitals after having sex with a female sex worker.

"Our data raises concerns about the future heterosexual transmission of HIV to the general population in China since unprotected sex with female sex workers has become the norm," said Kenrad Nelson, MD, senior author of the study and professor in the Department of Epidemiology at the Bloomberg School of Public Health.

Authors of "HIV, syphilis, hepatitis C and risk behaviours among commercial sex male clients in Sichuan province, China" include Carl Latkin and Cunling Wang of the Bloomberg School of Public Health, and Rongsheng Luan of the West China School of Public Health at Sichuan University.


Contact: Tim Parsons
Johns Hopkins University Bloomberg School of Public Health

Related biology news :

1. Long-term study shows effect of climate change on animal diversity
2. £2 million study to reveal workings of dementia genes
3. New study looks to define evangelicals and how they affect polling
4. CU-Boulder study suggests air quality regulations miss key pollutants
5. Researchers study acoustic communication in deep-sea fish
6. Study reveals homeowner perceptions in fire-prone areas
7. Researchers study how pistachios may improve heart health
8. Study: urban black bears live fast, die young
9. New study indicates link between weight gains during pregnancy and dieting history
10. Study reveals specific gene in adolescent men with delinquent peers
11. Sweat it out: UH study examines ability of sweat patches to monitor bone loss
Post Your Comments:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... 2016 adds 2016 ... its pharmaceuticals section with historic and forecast data ... more. Complete report on the Cell ... 15 companies and supported with 261 tables and ... . The Global Cell Culture Media ...
Breaking Biology Technology: